31 October 2003 PreAnalytiX and Affymetrix Collaborate to Improve Gene Expression Results from Whole Blood RNA Samples.
Click here for press release (PDF, 108KB)

21 March 2003 Joint letter between PreAnalytiX and Affymetrix to customers using the PAXgene™ with Affymetrix GeneChip® Arrays for expression analysis.
Click here for joint letter (PDF, 79KB)

06 August 2002 HOMBRECHTIKON, Switzerland, Aug. 6 2002 /PRNewswire/ -- PreAnalytiX GmbH, an equally owned joint venture between QIAGEN N.V. (Nasdaq: QGENF, Frankfurt Neuer Markt: QIA, Easdaq: QGEN) and BD (Becton, Dickinson and Company) (NYSE: BDX - News) announced today that they have been successful in forming agreements with a series of QIAGEN customers including GlaxoSmithKline (NYSE: GSK - News) for the use of the PreAnalytiX system.
Click here for full story (PDF, 66KB)

18 April 2001 PreAnalytiX GmbH, an equally owned joint venture between QIAGEN N.V. (Nasdaq: QGENF, Frankfurt Neuer Markt: QIA, Easdaq: QGEN) and BD (Becton, Dickinson and Company) (NYSE: BDX) announces the launch of its first product, the PAXgene™ Blood RNA System.
Click here for full story (PDF, 109KB)

Home | Products | Customer Service | News & Events | Technical Library | Company | Contact Us

©2007 PreAnalytiX GmbH    All rights reserved

PAXgene and PreAnalytix are registered trademarks of PreAnalytiX GmbH. Unless otherwise noted, BD and all other trademarks are property of Becton, Dickinson and Company.

"PAXgene 96 Blood RNA and PAXgene Blood RNA MDX kits are intended for general laboratory use. PAXgene Bone Marrow RNA, and PAXgene DNA Systems are intended for Research Use Only. The product's performance characteristics and safety and efficacy have not been established and have not been submitted for review by the FDA. Therefore this product may not be used for patient diagnosis or evaluation of disease."